The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lipocine Inc(NASDAQ:LPCN) 
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of...
Lipocine Days Payable Outstanding ttm (DPO)
Lipocine Days Receivable Outstanding ttm (DSO)
Lipocine Op Cashflow Per Share ttm
Lipocine Free Cashflow Per Share ttm
Lipocine Cash Per Share ttm
Lipocine P/S ratio ttm
Lipocine (GAAP) P/E ratio ttm
Lipocine P/B ratio ttm
No extra charts and metrics for this ticker.